In contrast, irisin levels appear to be higher in dysmetabolic states [42], such as obesity [43,44], possibly reflecting a condition of irisin resistance or a compensatory increase for the metabolic abnormalities and insulin resistance characteristic of these patients [44]. This evidence concerns the gene FNDC5 and obesity disorder.